DIA 2023: Venkatraman Balasubramanian Discusses Broader Supply Chain Issues

There is no doubt that drug shortages are a detriment to the pharma supply chain, but how commonplace were they during the COVID era?

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

Panel discussion addresses how DE&I can successfully tackle systemic biases and more.

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

A panel uncovers the value in meeting carbon-neutral goals by 2030.

Panel discussion uncovers how to alter one’s digital know-how for use in temperature-controlled supply chain.